<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04724655</url>
  </required_header>
  <id_info>
    <org_study_id>oils and aluminum phosphide</org_study_id>
    <nct_id>NCT04724655</nct_id>
  </id_info>
  <brief_title>Paraffin Oil or Coconut Oil in Acute Aluminum Phosphide Poisoning</brief_title>
  <official_title>Gastric Lavage With Paraffin Oil or Coconut Oil in Management of Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate safety and efficacy of gastric lavage with&#xD;
      paraffin oil or gastric lavage with coconut oil in management of acute Aluminum phosphide&#xD;
      poisoning.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      90 patients will be randomly assigned as control groups, paraffin group, and coconut group in&#xD;
      a 1:1:1 ratio (30 patients in each group).&#xD;
&#xD;
      Inclusion criteria:&#xD;
&#xD;
        -  Patients with symptomatic acute aluminum phosphide poisoning&#xD;
&#xD;
        -  Age is more than 12 years of both gender&#xD;
&#xD;
        -  Patients presenting within 6 hours post-ingestion of aluminum phosphide (Papade and&#xD;
           Vanjari, 2019).&#xD;
&#xD;
      The diagnosis is made on the basis of:&#xD;
&#xD;
        1. The suggestive clinical manifestations due to and following shortly after a single&#xD;
           exposure to aluminum phosphide.&#xD;
&#xD;
        2. Reliable identification of the compound based on the container brought by patient&#xD;
           attendants.&#xD;
&#xD;
        3. Biochemical detection of phosphine gas in gastric aspirate (silver nitrate test).&#xD;
&#xD;
             -  Group (I): Gastric lavage with saline and sodium bicarbonate 8.4% then aspiration&#xD;
                will be done after 3-5 min through nasogastric tube (Control group)&#xD;
&#xD;
             -  Group (II): Gastric lavage will be initiated with 50 mL of Paraffin oil and 50 mL&#xD;
                of sodium bicarbonate solution 8.4%, then aspiration will be done after 3-5 min&#xD;
                through nasogastric tube (Paraffin group).&#xD;
&#xD;
             -  Group (III): Gastric lavage will be initiated with 50 ml coconut oil and 50 ml&#xD;
                sodium bicarbonate 8.4 % then aspiration will be done after 3-5 min through&#xD;
                nasogastric tube (Coconut group).&#xD;
&#xD;
             -  All patients will continue to receive the standard supportive treatment according&#xD;
                to Tanta University Poison Control Center protocol, which is determined by the&#xD;
                attending physician who maintains clinical responsibility for all patients.&#xD;
                Conventional standard treatment included using inotropes, fluids and electrolytes&#xD;
                resuscitation, intubation, mechanical ventilation and antiarrhythmic agents if&#xD;
                indicated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 2021</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>death</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Aluminum Phosphide Poisoning</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>gastric lavage with saline and bicarbonate and standard treatment :inotropes as levophid, fluids and electrolytes , endotracheal intubation, mechanical ventilation and antiarrhythmic agents as Magnesium sulfate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paraffin group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>gastric lavage with paraffin oil and bicarbonate and standard treatment :inotropes as levophid, fluids and electrolytes , endotracheal intubation, mechanical ventilation and antiarrhythmic agents as Magnesium sulfate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>coconut group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>gastric lavage with coconut oil and bicarbonate and standard treatment :inotropes as levophid, fluids and electrolytes , endotracheal intubation, mechanical ventilation and antiarrhythmic agents as Magnesium sulfate</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>gastric lavage with paraffin oil and bicarbonate</intervention_name>
    <description>Gastric lavage will be initiated with 50 mL of Paraffin oil and 50 mL of sodium bicarbonate solution 8.4%, then aspiration will be done after 3-5 min through nasogastric tube</description>
    <arm_group_label>paraffin group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>gastric lavage with coconut oil and bicarbonate</intervention_name>
    <description>Gastric lavage will be initiated with 50 ml coconut oil and 50 ml sodium bicarbonate 8.4 % then aspiration will be done after 3-5 min through nasogastric tube</description>
    <arm_group_label>coconut group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard treatment</intervention_name>
    <description>inotropes as levophid, fluids and electrolytes , endotracheal intubation, mechanical ventilation and antiarrhythmic agents as Magnesium sulfate</description>
    <arm_group_label>coconut group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>paraffin group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>gastric lavage with saline and bicarbonate</intervention_name>
    <description>Gastric lavage with saline and sodium bicarbonate 8.4% then aspiration will be done after 3-5 min through nasogastric tube</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Patients with symptomatic acute aluminum phosphide poisoning&#xD;
&#xD;
               -  Age is more than 12 years of both gender&#xD;
&#xD;
               -  Patients presenting within 6 hours post-ingestion of aluminum phosphide&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Patients less than 12 years of age&#xD;
&#xD;
               -  Pregnant and lactating women.&#xD;
&#xD;
               -  Patients with ingestion or exposure to other substances in addition to aluminum&#xD;
                  phosphide.&#xD;
&#xD;
               -  Patients with other major medical conditions (e.g. cardiovascular disease,&#xD;
                  diabetes mellitus, renal or hepatic failure).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tantau</name>
      <address>
        <city>Tanta</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>samah maher, Phd</last_name>
      <phone>00201032636965</phone>
      <email>doctor_samahmaher@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>alshimaa elmansy, phd</last_name>
      <phone>002001067702858</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2021</study_first_posted>
  <last_update_submitted>January 22, 2021</last_update_submitted>
  <last_update_submitted_qc>January 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>samah maher</investigator_full_name>
    <investigator_title>faculty of medicine,tanta university,Tanta Elgeesh street,qism 2,Egypt</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mineral Oil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

